CN114404527B - Traditional Chinese medicine composition for treating respiratory tract infection - Google Patents
Traditional Chinese medicine composition for treating respiratory tract infection Download PDFInfo
- Publication number
- CN114404527B CN114404527B CN202011170655.5A CN202011170655A CN114404527B CN 114404527 B CN114404527 B CN 114404527B CN 202011170655 A CN202011170655 A CN 202011170655A CN 114404527 B CN114404527 B CN 114404527B
- Authority
- CN
- China
- Prior art keywords
- acute
- respiratory tract
- tract infection
- shangganhe
- agent
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 206010057190 Respiratory tract infections Diseases 0.000 title claims abstract description 78
- 239000000203 mixture Substances 0.000 title claims abstract description 45
- 239000003814 drug Substances 0.000 title claims abstract description 24
- 235000020357 syrup Nutrition 0.000 claims abstract description 11
- 239000006188 syrup Substances 0.000 claims abstract description 11
- 201000007100 Pharyngitis Diseases 0.000 claims description 119
- 206010006451 bronchitis Diseases 0.000 claims description 45
- 208000020029 respiratory tract infectious disease Diseases 0.000 claims description 18
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 13
- 240000001659 Oldenlandia diffusa Species 0.000 claims description 11
- 235000014676 Phragmites communis Nutrition 0.000 claims description 11
- 238000002360 preparation method Methods 0.000 claims description 11
- 238000011282 treatment Methods 0.000 claims description 10
- 239000002994 raw material Substances 0.000 claims description 9
- 239000000706 filtrate Substances 0.000 claims description 8
- 241000951473 Schizonepeta Species 0.000 claims description 7
- 241000157352 Uncaria Species 0.000 claims description 7
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 claims description 7
- 229910052602 gypsum Inorganic materials 0.000 claims description 7
- 239000010440 gypsum Substances 0.000 claims description 7
- 206010039083 rhinitis Diseases 0.000 claims description 7
- 238000001914 filtration Methods 0.000 claims description 6
- 206010035664 Pneumonia Diseases 0.000 claims description 5
- 206010044008 tonsillitis Diseases 0.000 claims description 5
- 201000008197 Laryngitis Diseases 0.000 claims description 4
- 235000006679 Mentha X verticillata Nutrition 0.000 claims description 4
- 235000002899 Mentha suaveolens Nutrition 0.000 claims description 4
- 235000001636 Mentha x rotundifolia Nutrition 0.000 claims description 4
- 206010044302 Tracheitis Diseases 0.000 claims description 4
- 201000009240 nasopharyngitis Diseases 0.000 claims description 4
- 239000003755 preservative agent Substances 0.000 claims description 4
- 230000002335 preservative effect Effects 0.000 claims description 4
- 239000000546 pharmaceutical excipient Substances 0.000 claims description 2
- 239000002671 adjuvant Substances 0.000 claims 1
- 238000011321 prophylaxis Methods 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 6
- 239000002552 dosage form Substances 0.000 abstract description 5
- 230000001717 pathogenic effect Effects 0.000 abstract description 4
- 206010013663 drug dependence Diseases 0.000 abstract description 2
- 208000011117 substance-related disease Diseases 0.000 abstract description 2
- 208000016150 acute pharyngitis Diseases 0.000 description 114
- 239000003795 chemical substances by application Substances 0.000 description 112
- 206010046306 Upper respiratory tract infection Diseases 0.000 description 102
- 208000015181 infectious disease Diseases 0.000 description 49
- 230000006698 induction Effects 0.000 description 35
- 208000007442 rickets Diseases 0.000 description 20
- 230000001154 acute effect Effects 0.000 description 19
- 206010001093 acute tonsillitis Diseases 0.000 description 14
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 13
- 239000003242 anti bacterial agent Substances 0.000 description 12
- 229940088710 antibiotic agent Drugs 0.000 description 12
- 201000004813 Bronchopneumonia Diseases 0.000 description 9
- 201000010099 disease Diseases 0.000 description 9
- 239000000463 material Substances 0.000 description 9
- 235000009508 confectionery Nutrition 0.000 description 8
- 235000013376 functional food Nutrition 0.000 description 8
- 208000010668 atopic eczema Diseases 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 239000008194 pharmaceutical composition Substances 0.000 description 7
- 208000023504 respiratory system disease Diseases 0.000 description 7
- 206010006448 Bronchiolitis Diseases 0.000 description 6
- 208000002330 Congenital Heart Defects Diseases 0.000 description 6
- 206010024971 Lower respiratory tract infections Diseases 0.000 description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
- 206010037660 Pyrexia Diseases 0.000 description 6
- 206010047482 Viral upper respiratory tract infection Diseases 0.000 description 6
- 208000021240 acute bronchiolitis Diseases 0.000 description 6
- 230000000172 allergic effect Effects 0.000 description 6
- 208000028831 congenital heart disease Diseases 0.000 description 6
- 238000001035 drying Methods 0.000 description 6
- 235000013305 food Nutrition 0.000 description 6
- 239000012535 impurity Substances 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 238000003672 processing method Methods 0.000 description 6
- 239000000243 solution Substances 0.000 description 6
- 244000246386 Mentha pulegium Species 0.000 description 5
- 235000016257 Mentha pulegium Nutrition 0.000 description 5
- 235000004357 Mentha x piperita Nutrition 0.000 description 5
- 235000001050 hortel pimenta Nutrition 0.000 description 5
- -1 hydroxyphenyl ester Chemical class 0.000 description 5
- 230000002458 infectious effect Effects 0.000 description 5
- 238000000034 method Methods 0.000 description 5
- 230000002829 reductive effect Effects 0.000 description 5
- 235000019640 taste Nutrition 0.000 description 5
- 206010040047 Sepsis Diseases 0.000 description 4
- 238000004140 cleaning Methods 0.000 description 4
- 208000035475 disorder Diseases 0.000 description 4
- 201000006549 dyspepsia Diseases 0.000 description 4
- 210000004185 liver Anatomy 0.000 description 4
- 210000004072 lung Anatomy 0.000 description 4
- 229920000609 methyl cellulose Polymers 0.000 description 4
- 239000001923 methylcellulose Substances 0.000 description 4
- 235000010981 methylcellulose Nutrition 0.000 description 4
- 210000002784 stomach Anatomy 0.000 description 4
- 239000000375 suspending agent Substances 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 3
- 206010010741 Conjunctivitis Diseases 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 108010010803 Gelatin Proteins 0.000 description 3
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 3
- 235000013361 beverage Nutrition 0.000 description 3
- 230000001684 chronic effect Effects 0.000 description 3
- 238000005520 cutting process Methods 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 229960001617 ethyl hydroxybenzoate Drugs 0.000 description 3
- NUVBSKCKDOMJSU-UHFFFAOYSA-N ethylparaben Chemical compound CCOC(=O)C1=CC=C(O)C=C1 NUVBSKCKDOMJSU-UHFFFAOYSA-N 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 235000019322 gelatine Nutrition 0.000 description 3
- 235000011852 gelatine desserts Nutrition 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 229940016286 microcrystalline cellulose Drugs 0.000 description 3
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 3
- 239000008108 microcrystalline cellulose Substances 0.000 description 3
- 238000002156 mixing Methods 0.000 description 3
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 3
- 239000000843 powder Substances 0.000 description 3
- 208000006155 precocious puberty Diseases 0.000 description 3
- 239000000047 product Substances 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 206010037844 rash Diseases 0.000 description 3
- 206010002198 Anaphylactic reaction Diseases 0.000 description 2
- QFOHBWFCKVYLES-UHFFFAOYSA-N Butylparaben Chemical compound CCCCOC(=O)C1=CC=C(O)C=C1 QFOHBWFCKVYLES-UHFFFAOYSA-N 0.000 description 2
- 206010059866 Drug resistance Diseases 0.000 description 2
- 208000029836 Inguinal Hernia Diseases 0.000 description 2
- 206010023126 Jaundice Diseases 0.000 description 2
- 241000207923 Lamiaceae Species 0.000 description 2
- 206010029096 Neoplasm prostate Diseases 0.000 description 2
- 241000249899 Populus tomentosa Species 0.000 description 2
- 208000001431 Psychomotor Agitation Diseases 0.000 description 2
- 206010038743 Restlessness Diseases 0.000 description 2
- 241001107098 Rubiaceae Species 0.000 description 2
- 241000700605 Viruses Species 0.000 description 2
- 206010047700 Vomiting Diseases 0.000 description 2
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 2
- 230000036783 anaphylactic response Effects 0.000 description 2
- 208000003455 anaphylaxis Diseases 0.000 description 2
- WPYMKLBDIGXBTP-UHFFFAOYSA-N benzoic acid Chemical compound OC(=O)C1=CC=CC=C1 WPYMKLBDIGXBTP-UHFFFAOYSA-N 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 239000001913 cellulose Substances 0.000 description 2
- 201000009151 chronic rhinitis Diseases 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- 230000007613 environmental effect Effects 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 230000036039 immunity Effects 0.000 description 2
- 230000009545 invasion Effects 0.000 description 2
- 239000006210 lotion Substances 0.000 description 2
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 description 2
- LXCFILQKKLGQFO-UHFFFAOYSA-N methylparaben Chemical compound COC(=O)C1=CC=C(O)C=C1 LXCFILQKKLGQFO-UHFFFAOYSA-N 0.000 description 2
- 239000003094 microcapsule Substances 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- GYCKQBWUSACYIF-UHFFFAOYSA-N o-hydroxybenzoic acid ethyl ester Natural products CCOC(=O)C1=CC=CC=C1O GYCKQBWUSACYIF-UHFFFAOYSA-N 0.000 description 2
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 2
- 238000004806 packaging method and process Methods 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 238000010298 pulverizing process Methods 0.000 description 2
- 235000019633 pungent taste Nutrition 0.000 description 2
- 239000013558 reference substance Substances 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 235000020374 simple syrup Nutrition 0.000 description 2
- 239000007901 soft capsule Substances 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 238000005507 spraying Methods 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 229940126680 traditional chinese medicines Drugs 0.000 description 2
- 235000014101 wine Nutrition 0.000 description 2
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- CHHHXKFHOYLYRE-UHFFFAOYSA-M 2,4-Hexadienoic acid, potassium salt (1:1), (2E,4E)- Chemical compound [K+].CC=CC=CC([O-])=O CHHHXKFHOYLYRE-UHFFFAOYSA-M 0.000 description 1
- MIJYXULNPSFWEK-GTOFXWBISA-N 3beta-hydroxyolean-12-en-28-oic acid Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C(O)=O)CCC(C)(C)C[C@H]5C4=CC[C@@H]3[C@]21C MIJYXULNPSFWEK-GTOFXWBISA-N 0.000 description 1
- 208000004998 Abdominal Pain Diseases 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- 239000005711 Benzoic acid Substances 0.000 description 1
- 241000276694 Carangidae Species 0.000 description 1
- 229920001661 Chitosan Polymers 0.000 description 1
- 206010009152 Chronic tonsillitis Diseases 0.000 description 1
- 208000035473 Communicable disease Diseases 0.000 description 1
- 206010010774 Constipation Diseases 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 229920002785 Croscarmellose sodium Polymers 0.000 description 1
- UDIPTWFVPPPURJ-UHFFFAOYSA-M Cyclamate Chemical compound [Na+].[O-]S(=O)(=O)NC1CCCCC1 UDIPTWFVPPPURJ-UHFFFAOYSA-M 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- 206010011844 Dacryocystitis Diseases 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 206010012444 Dermatitis diaper Diseases 0.000 description 1
- 208000003105 Diaper Rash Diseases 0.000 description 1
- 206010058314 Dysplasia Diseases 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014909 Enterovirus infection Diseases 0.000 description 1
- JKLISIRFYWXLQG-UHFFFAOYSA-N Epioleonolsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4CCC3C21C JKLISIRFYWXLQG-UHFFFAOYSA-N 0.000 description 1
- 206010015150 Erythema Diseases 0.000 description 1
- 208000010201 Exanthema Diseases 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 208000035211 Heart Murmurs Diseases 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 208000019637 Infantile Diarrhea Diseases 0.000 description 1
- 235000010643 Leucaena leucocephala Nutrition 0.000 description 1
- 240000007472 Leucaena leucocephala Species 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 235000014435 Mentha Nutrition 0.000 description 1
- 241001072983 Mentha Species 0.000 description 1
- 244000245214 Mentha canadensis Species 0.000 description 1
- 235000001878 Mentha haplocalyx Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000881 Modified starch Polymers 0.000 description 1
- 229920000715 Mucilage Polymers 0.000 description 1
- 208000005647 Mumps Diseases 0.000 description 1
- 241000204031 Mycoplasma Species 0.000 description 1
- WHNWPMSKXPGLAX-UHFFFAOYSA-N N-Vinyl-2-pyrrolidone Chemical compound C=CN1CCCC1=O WHNWPMSKXPGLAX-UHFFFAOYSA-N 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 206010030113 Oedema Diseases 0.000 description 1
- YBRJHZPWOMJYKQ-UHFFFAOYSA-N Oleanolic acid Natural products CC1(C)CC2C3=CCC4C5(C)CCC(O)C(C)(C)C5CCC4(C)C3(C)CCC2(C1)C(=O)O YBRJHZPWOMJYKQ-UHFFFAOYSA-N 0.000 description 1
- MIJYXULNPSFWEK-UHFFFAOYSA-N Oleanolinsaeure Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C(O)=O)CCC(C)(C)CC5C4=CCC3C21C MIJYXULNPSFWEK-UHFFFAOYSA-N 0.000 description 1
- 206010033079 Otitis media acute Diseases 0.000 description 1
- 244000273256 Phragmites communis Species 0.000 description 1
- 241000425347 Phyla <beetle> Species 0.000 description 1
- 241000209504 Poaceae Species 0.000 description 1
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 241000219000 Populus Species 0.000 description 1
- 241000951376 Schizonepeta tenuifolia Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 208000004367 Tibial Fractures Diseases 0.000 description 1
- 206010044314 Tracheobronchitis Diseases 0.000 description 1
- 206010064466 Trunk deformities Diseases 0.000 description 1
- 241000123748 Uncaria macrophylla Species 0.000 description 1
- 241000157373 Uncaria rhynchophylla Species 0.000 description 1
- 241000123749 Uncaria sessilifructus Species 0.000 description 1
- 241000214513 Uncaria sinensis Species 0.000 description 1
- 241000607122 Uncaria tomentosa Species 0.000 description 1
- 208000001910 Ventricular Heart Septal Defects Diseases 0.000 description 1
- 206010047626 Vitamin D Deficiency Diseases 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 208000038016 acute inflammation Diseases 0.000 description 1
- 230000006022 acute inflammation Effects 0.000 description 1
- 239000000853 adhesive Substances 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 239000000443 aerosol Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 229910052925 anhydrite Inorganic materials 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000010233 benzoic acid Nutrition 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 201000009267 bronchiectasis Diseases 0.000 description 1
- 210000001217 buttock Anatomy 0.000 description 1
- 229940067596 butylparaben Drugs 0.000 description 1
- 230000001914 calming effect Effects 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000011472 cat’s claw Nutrition 0.000 description 1
- 210000004027 cell Anatomy 0.000 description 1
- OAIVIYSBZFEOIU-UHFFFAOYSA-N chloroform;propan-2-one Chemical compound CC(C)=O.ClC(Cl)Cl OAIVIYSBZFEOIU-UHFFFAOYSA-N 0.000 description 1
- 201000005471 chronic dacryocystitis Diseases 0.000 description 1
- 239000008395 clarifying agent Substances 0.000 description 1
- 238000003759 clinical diagnosis Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 210000000860 cochlear nerve Anatomy 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000036461 convulsion Effects 0.000 description 1
- 229920001531 copovidone Polymers 0.000 description 1
- 229960001681 croscarmellose sodium Drugs 0.000 description 1
- 235000010947 crosslinked sodium carboxy methyl cellulose Nutrition 0.000 description 1
- 239000000625 cyclamic acid and its Na and Ca salt Substances 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 208000036654 deficiency anemia Diseases 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 239000000428 dust Substances 0.000 description 1
- 239000003221 ear drop Substances 0.000 description 1
- 229940047652 ear drops Drugs 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 231100000321 erythema Toxicity 0.000 description 1
- ROAYSRAUMPWBQX-UHFFFAOYSA-N ethanol;sulfuric acid Chemical compound CCO.OS(O)(=O)=O ROAYSRAUMPWBQX-UHFFFAOYSA-N 0.000 description 1
- BEFDCLMNVWHSGT-UHFFFAOYSA-N ethenylcyclopentane Chemical compound C=CC1CCCC1 BEFDCLMNVWHSGT-UHFFFAOYSA-N 0.000 description 1
- 235000010228 ethyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004403 ethyl p-hydroxybenzoate Substances 0.000 description 1
- 201000005884 exanthem Diseases 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 235000003599 food sweetener Nutrition 0.000 description 1
- 239000013022 formulation composition Substances 0.000 description 1
- FTSSQIKWUOOEGC-RULYVFMPSA-N fructooligosaccharide Chemical compound OC[C@H]1O[C@@](CO)(OC[C@@]2(OC[C@@]3(OC[C@@]4(OC[C@@]5(OC[C@@]6(OC[C@@]7(OC[C@@]8(OC[C@@]9(OC[C@@]%10(OC[C@@]%11(O[C@H]%12O[C@H](CO)[C@@H](O)[C@H](O)[C@H]%12O)O[C@H](CO)[C@@H](O)[C@@H]%11O)O[C@H](CO)[C@@H](O)[C@@H]%10O)O[C@H](CO)[C@@H](O)[C@@H]9O)O[C@H](CO)[C@@H](O)[C@@H]8O)O[C@H](CO)[C@@H](O)[C@@H]7O)O[C@H](CO)[C@@H](O)[C@@H]6O)O[C@H](CO)[C@@H](O)[C@@H]5O)O[C@H](CO)[C@@H](O)[C@@H]4O)O[C@H](CO)[C@@H](O)[C@@H]3O)O[C@H](CO)[C@@H](O)[C@@H]2O)[C@@H](O)[C@@H]1O FTSSQIKWUOOEGC-RULYVFMPSA-N 0.000 description 1
- 229940107187 fructooligosaccharide Drugs 0.000 description 1
- 230000002496 gastric effect Effects 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 210000003714 granulocyte Anatomy 0.000 description 1
- 210000003128 head Anatomy 0.000 description 1
- 235000013402 health food Nutrition 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 206010020488 hydrocele Diseases 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 239000001866 hydroxypropyl methyl cellulose Substances 0.000 description 1
- 235000010979 hydroxypropyl methyl cellulose Nutrition 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- UFVKGYZPFZQRLF-UHFFFAOYSA-N hydroxypropyl methyl cellulose Chemical compound OC1C(O)C(OC)OC(CO)C1OC1C(O)C(O)C(OC2C(C(O)C(OC3C(C(O)C(O)C(CO)O3)O)C(CO)O2)O)C(CO)O1 UFVKGYZPFZQRLF-UHFFFAOYSA-N 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000010253 intravenous injection Methods 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 210000000265 leukocyte Anatomy 0.000 description 1
- 230000000670 limiting effect Effects 0.000 description 1
- 229940031703 low substituted hydroxypropyl cellulose Drugs 0.000 description 1
- 239000007937 lozenge Substances 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 235000019359 magnesium stearate Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 235000010270 methyl p-hydroxybenzoate Nutrition 0.000 description 1
- 239000004292 methyl p-hydroxybenzoate Substances 0.000 description 1
- 229960002216 methylparaben Drugs 0.000 description 1
- 244000000010 microbial pathogen Species 0.000 description 1
- 230000027939 micturition Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 150000002772 monosaccharides Chemical class 0.000 description 1
- 208000010805 mumps infectious disease Diseases 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 229940100662 nasal drops Drugs 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 230000035764 nutrition Effects 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- 229940100243 oleanolic acid Drugs 0.000 description 1
- 244000045947 parasite Species 0.000 description 1
- 239000002304 perfume Substances 0.000 description 1
- 210000003516 pericardium Anatomy 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 235000010241 potassium sorbate Nutrition 0.000 description 1
- 239000004302 potassium sorbate Substances 0.000 description 1
- 229940069338 potassium sorbate Drugs 0.000 description 1
- 229940069328 povidone Drugs 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- HZLWUYJLOIAQFC-UHFFFAOYSA-N prosapogenin PS-A Natural products C12CC(C)(C)CCC2(C(O)=O)CCC(C2(CCC3C4(C)C)C)(C)C1=CCC2C3(C)CCC4OC1OCC(O)C(O)C1O HZLWUYJLOIAQFC-UHFFFAOYSA-N 0.000 description 1
- 238000010926 purge Methods 0.000 description 1
- 201000009259 purulent acute otitis media Diseases 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 230000000171 quenching effect Effects 0.000 description 1
- 230000000306 recurrent effect Effects 0.000 description 1
- 239000013074 reference sample Substances 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 210000004706 scrotum Anatomy 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- 239000009874 shenqi Substances 0.000 description 1
- 208000017520 skin disease Diseases 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 210000000813 small intestine Anatomy 0.000 description 1
- 235000015424 sodium Nutrition 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 229960001462 sodium cyclamate Drugs 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 235000010199 sorbic acid Nutrition 0.000 description 1
- 239000004334 sorbic acid Substances 0.000 description 1
- 229940075582 sorbic acid Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000021259 spicy food Nutrition 0.000 description 1
- 230000005982 spleen dysfunction Effects 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 229940032147 starch Drugs 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 229940013618 stevioside Drugs 0.000 description 1
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 description 1
- 235000019202 steviosides Nutrition 0.000 description 1
- 230000005985 stomach dysfunction Effects 0.000 description 1
- 239000004575 stone Substances 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 229960004793 sucrose Drugs 0.000 description 1
- 229910052600 sulfate mineral Inorganic materials 0.000 description 1
- 239000000829 suppository Substances 0.000 description 1
- 235000021147 sweet food Nutrition 0.000 description 1
- 239000003765 sweetening agent Substances 0.000 description 1
- 208000011580 syndromic disease Diseases 0.000 description 1
- 239000012085 test solution Substances 0.000 description 1
- QIQCZROILFZKAT-UHFFFAOYSA-N tetracarbon dioxide Chemical group O=C=C=C=C=O QIQCZROILFZKAT-UHFFFAOYSA-N 0.000 description 1
- 238000004809 thin layer chromatography Methods 0.000 description 1
- 230000035922 thirst Effects 0.000 description 1
- 231100000331 toxic Toxicity 0.000 description 1
- 230000002588 toxic effect Effects 0.000 description 1
- 201000003130 ventricular septal defect Diseases 0.000 description 1
- 230000003612 virological effect Effects 0.000 description 1
- 230000008673 vomiting Effects 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
- A61K36/748—Oldenlandia or Hedyotis
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/534—Mentha (mint)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/53—Lamiaceae or Labiatae (Mint family), e.g. thyme, rosemary or lavender
- A61K36/538—Schizonepeta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/74—Rubiaceae (Madder family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/02—Nasal agents, e.g. decongestants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/04—Drugs for disorders of the respiratory system for throat disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/30—Extraction of the material
- A61K2236/33—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones
- A61K2236/331—Extraction of the material involving extraction with hydrophilic solvents, e.g. lower alcohols, esters or ketones using water, e.g. cold water, infusion, tea, steam distillation, decoction
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Medical Informatics (AREA)
- Alternative & Traditional Medicine (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pulmonology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Otolaryngology (AREA)
- Nutrition Science (AREA)
- Polymers & Plastics (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Inorganic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
The invention discloses a traditional Chinese medicine composition for treating respiratory tract infection. The Chinese medicinal composition has effects of clearing heat and detoxicating, dispelling pathogenic wind and dispelling cold, and can not cause drug dependence of patients, especially dosage forms such as mixture and syrup, which are easy to be accepted by patients (especially children), and has good compliance of patients, and is helpful for improving curative effect.
Description
Technical Field
The invention relates to the technical field of traditional Chinese medicines, in particular to a traditional Chinese medicine composition for treating respiratory tract infection (especially respiratory tract infection of children) and a preparation method thereof.
Background
Respiratory tract infections are one of the most common infectious diseases and can be classified into upper respiratory tract infections and lower respiratory tract infections. Upper respiratory tract infections refer to the general term for acute inflammation between the nasal cavity and the throat. Lower respiratory tract infections include bronchitis, pneumonia, bronchiectasis, and the like.
The cause of respiratory tract infections is thought to be caused by external and internal factors. The external factors include: 1. environmental pollution such as dust, haze and the like easily cause heavy moisture in external environment air, especially in spring, summer and autumn, the heavy moisture easily causes heat not to be easily dissipated, air humidity and stuffy is caused, people are easily invaded by humidity Wen Bingxie, and the people are easily suffered from wet temperature disease. The damp-warm disease evil in traditional Chinese medicine includes pathogenic bacteria of respiratory tract infection in Western medicine clinic, such as: bacteria, viruses, etc.; 2. the temperature difference of the environment is greatly changed, such as factors of cold, uneven cold and heat caused by improper use of an air conditioner, time and heat and the like; 3. adverse dietary structure effects, such as: people often eat cold and greasy food, often eat sweet and spicy food, often eat hot pot and wine, and easily turn heat in the body, so that modern constitutions are easy to form damp-heat constitutions due to environmental and dietary structure changes. Although the internal factors (such as deficiency of spleen and stomach) are normal in diet, there is a slight invasion of exogenous pathogenic factors, which tends to cause damp-heat to generate internally.
In the past, antibiotics are most commonly used for clinically treating respiratory tract infection. However, antibiotics also bring a lot of harm to human bodies while treating diseases: 1. the patients are affected by the environment and enter the body by pathogenic factors, and the drug resistance to antibiotics is easy to generate through the treatment of pure antibiotics, so that the medical cost of the patients is increased intangibly; 2. meanwhile, the use of antibiotics can increase the anaphylaxis rate, and the antibiotics which need to do skin test or do not need to do skin test can be used as a variant source, so that the human body can be allergic, the anaphylaxis rate of people with damp-heat constitution can be higher, various allergic skin diseases can be easily caused by slight anaphylactic hazard, and the death of the human body can be seriously caused; 3. the antibiotics are used for killing bacteria and simultaneously have great influence on normal cells of a human body, and the number of white blood cells of the human body is easily reduced and the immunity is easily reduced when the antibiotics are used frequently or for a long time; the patients are treated by the simple antibiotics, the environmental causes are not eliminated, the damp-heat physique is not changed, the immunity is reduced, the patients are easy to get ill again, the antibiotics are easy to form dependence on medicines, the drug resistance is increased, the allergic probability, the range and the degree are increased, the damp-heat allergic physique is easy to form, the prior non-allergic antibiotics can be allergic, the physique of the human body is further reduced, the treatment effect and the safety of the antibiotics are further reduced, and the vicious circle is formed.
The infant and children have low immune function, especially the children mostly like instant food at present, and various beverages are used for replacing water drinking, so that spleen and stomach dysfunction, gastrointestinal stagnation and morbidity are more common. However, some of the medicines on the market at present are not suitable for infants and children, and some of the medicines can be used for children, but the curative effect is not exact, or the dosage form and the taste of the product are not acceptable for children, so that the compliance of taking medicines for children is poor.
Disclosure of Invention
In order to overcome the defects in the prior art, the invention provides a composition which is prepared from the following traditional Chinese medicine raw materials in parts by weight: 50-150 parts of oldenlandia diffusa, 50-150 parts of gypsum, 50-100 parts of reed rhizome, 10-50 parts of schizonepeta, 30-60 parts of uncaria, and 10-50 parts of peppermint.
In one embodiment of the invention, the traditional Chinese medicinal materials consist of the following components in parts by weight: 50-150 parts of oldenlandia diffusa, 50-150 parts of gypsum, 50-100 parts of reed rhizome, 10-50 parts of schizonepeta, 30-60 parts of uncaria, and 10-50 parts of peppermint.
Specifically, the weight fraction of the oldenlandia diffusa in the traditional Chinese medicine raw materials can be 50, 60, 70, 80, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 120, 130, 140 and 150 parts.
Specifically, in the traditional Chinese medicine raw materials, the weight fraction of the gypsum can be 50, 60, 70, 80, 90, 91, 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 107, 108, 109, 110, 120, 130, 140 and 150 parts.
Specifically, the weight fraction of the reed rhizome in the traditional Chinese medicine raw materials can be 50, 60, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81, 82, 83, 84, 85, 90 and 100 parts.
Specifically, in the traditional Chinese medicine raw materials, the weight fraction of the schizonepeta can be 10, 15, 20, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 40, 45 and 50 parts.
Specifically, the weight fraction of ramulus Uncariae cum Uncis in the above Chinese medicinal materials may be 30, 35, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 55, 60 parts.
Specifically, the weight fraction of the mint in the traditional Chinese medicine raw materials can be 10, 15, 20, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 40, 45 and 50 parts.
In one embodiment of the invention, the composition is prepared from the following traditional Chinese medicine raw materials in parts by weight: 100 parts of oldenlandia diffusa, 100 parts of gypsum, 75 parts of reed rhizome, 30 parts of schizonepeta, 45 parts of uncaria and 30 parts of mint.
In one embodiment of the invention, the traditional Chinese medicinal materials consist of the following components in parts by weight: 100 parts of oldenlandia diffusa, 100 parts of gypsum, 75 parts of reed rhizome, 30 parts of schizonepeta, 45 parts of uncaria and 30 parts of mint.
In one embodiment of the invention, the above composition is a pharmaceutical composition.
Specifically, the pharmaceutical composition further comprises pharmaceutically acceptable auxiliary materials.
Specifically, the pharmaceutically acceptable auxiliary materials may include a taste corrigent (specifically, sucrose, xylitol, fructo-oligosaccharide, sodium cyclamate, stevioside, aspartame, monosaccharide syrup, etc.), an aromatic agent (such as perfume, essence, etc.), a mucilage agent (specifically, sodium alginate, acacia, gelatin, methylcellulose, sodium carboxymethylcellulose, etc.), a clarifying agent (specifically, chitosan, gelatin, etc.), a preservative (specifically, benzoic acid and salts thereof (e.g., sodium benzoate), sorbic acid and salts thereof (e.g., potassium sorbate), a hydroxyphenyl ester (e.g., methylparaben, ethylparaben, butylparaben, etc.), a disintegrating agent (specifically, low-substituted hydroxypropylcellulose, croscarmellose sodium, starch, etc.), a binder (specifically, hydroxypropyl cellulose, hydroxypropyl methylcellulose, povidone, copovidone, pregelatinized starch, etc.), a lubricant (specifically, stearic acid, magnesium stearate, sodium fumaryl stearate, etc.), a wetting agent (specifically, sorbitol, polyoxyethylene sorbitan, castor oil, polyoxyethylene castor oil, etc.), a suspending agent (specifically, methylcellulose, a suspending agent, such as methylcellulose, a microcrystalline cellulose, a suspending agent, a microcrystalline cellulose, a suspending agent (specifically, a methylcellulose, a microcrystalline cellulose, a cellulose, etc.), cellulose derivatives, alginates, gelatin, polyvinylpyrrolidone, and the like), and the like.
Specifically, the above pharmaceutical composition may be in any dosage form or administration form, and those skilled in the art may choose according to circumstances, including, but not limited to, tablets, pills, powders, ointments, granules, lozenges, gums, capsules (including soft capsules, microcapsules), syrups, mixtures, wines, tinctures, lotions, injections (e.g., subcutaneous injections, intravenous injections, intramuscular injections, intraperitoneal injections), aerosols, films, suppositories, lotions, eye drops, ear drops, nose drops, and the like.
In one embodiment of the present invention, the pharmaceutical composition is a liquid medicament.
In one embodiment of the present invention, the pharmaceutical composition is a mixture.
Specifically, the solvent used in the preparation of the mixture is water.
In one embodiment of the present invention, the pharmaceutical composition is a syrup.
The various dosage forms of the above pharmaceutical composition may be prepared according to conventional production methods in the pharmaceutical field.
Specifically, the preparation method of the mixture comprises the following steps:
(1) Decocting Gypsum Fibrosum in water;
(2) Adding oldenlandia diffusa and reed rhizome into the decoction obtained in the step (1), decocting and filtering;
(3) Decocting herba Schizonepetae, ramulus Uncariae cum Uncis, and herba Menthae in water, and filtering;
(4) And (3) combining the filtrates obtained in the steps (2) and (3).
Specifically, the decoction in step (2) may be 1 or more times (e.g., 2, 3, 4, etc.).
Specifically, the step (2) may further include a step of concentrating the filtrate.
Specifically, the decoction in step (3) may be 1 or more times (e.g., 2, 3, 4 times, etc.).
Specifically, the step (3) may further include a step of concentrating the filtrate.
Specifically, the step (4) may further include a step of adding pharmaceutically acceptable auxiliary materials.
Specifically, the above preparation method may further comprise a step of sterilization.
Specifically, the preparation method can further comprise the step of sub-packaging.
Specifically, the preparation method of the syrup comprises the preparation method steps of the mixture, and the step (4) further comprises the step of adding syrup.
In one embodiment of the present invention, the syrup may be a simple syrup.
Specifically, the syrup also comprises a preservative.
In one embodiment of the present invention, the preservative is ethyl hydroxy benzoate.
In one embodiment of the present invention, the composition is a functional food composition.
Specifically, the functional food composition further comprises food auxiliary materials.
Specifically, the food auxiliary materials can comprise one or more of excipient, filler, forming agent, sweetener, colorant, coating agent, acidity regulator and the like.
Specifically, the above-mentioned functional food composition may take any form, such as tablets, pills, capsules (e.g., soft capsules, microcapsules), candies (e.g., tableted candies, gel candies, gum base candies, etc.), solid beverages (e.g., powders, granules, etc.), liquid beverages, etc.
The various forms of the above-described functional food composition may be prepared according to conventional production methods in the functional food field.
The invention also provides application of the composition in preparing medicines for preventing and/or treating respiratory tract infection.
The invention also provides application of the composition in preparing functional food for preventing respiratory tract infection or assisting in treating respiratory tract infection.
Specifically, the above-mentioned respiratory tract infections include upper respiratory tract infections and lower respiratory tract infections, and specifically include, but are not limited to, cold, rhinitis, pharyngitis, laryngitis, tonsillitis, tracheitis, bronchitis and pneumonia.
Specifically, the respiratory tract infections include acute respiratory tract infections and chronic respiratory tract infections.
In one embodiment of the present invention, the respiratory tract infection is an upper respiratory tract infection.
In one embodiment of the present invention, the respiratory tract infection is an acute respiratory tract infection.
In particular, the patient suffering from respiratory tract infections is a human, in particular a child, such as a child aged 1-14, 1-10, in particular 1-5.
The present invention also provides a method of preventing and/or treating a respiratory tract infection or aiding in the prevention and/or treatment described above, comprising the step of administering to a subject a composition of the invention described above.
Specifically, the above-mentioned respiratory tract infections include upper respiratory tract infections and lower respiratory tract infections, and specifically include, but are not limited to, cold, rhinitis, pharyngitis, laryngitis, tonsillitis, tracheitis, bronchitis and pneumonia.
Specifically, the respiratory tract infections include acute respiratory tract infections and chronic respiratory tract infections.
In one embodiment of the present invention, the respiratory tract infection is an upper respiratory tract infection.
In one embodiment of the present invention, the respiratory tract infection is an acute respiratory tract infection.
In particular, the subject is a human, particularly a child, such as a child aged 1-14 years, 1-10 years, particularly 1-5 years.
Aiming at respiratory tract infection, especially children respiratory tract infection, the invention provides a traditional Chinese medicine composition which can clear away heat and toxic materials, dispel wind and remove cold, does not cause the patient to generate drug dependence, especially the dosage forms of mixture, syrup and the like, is easy to be accepted by the patient (especially children), has better medication compliance of the patient and is beneficial to improving the curative effect.
Detailed Description
Unless defined otherwise, all scientific and technical terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention relates.
The "respiratory tract infection" refers to a disease caused by invasion of pathogenic microorganisms (including bacteria, viruses, mycoplasma, fungi, parasites, etc.) into the respiratory tract and propagation, and can be classified into upper respiratory tract infection and lower respiratory tract infection according to the site of occurrence thereof, the former including common cold, rhinitis, pharyngitis, laryngitis, tonsillitis, etc., and the latter including tracheitis, bronchitis, pneumonia, etc. Respiratory tract infections in the present invention include acute respiratory tract infections (e.g. acute pharyngitis, acute rhinitis, acute bronchitis) and chronic respiratory tract infections (e.g. recurrent symptoms last for more than one month, e.g. chronic tonsillitis, chronic rhinitis), in particular acute upper respiratory tract infections.
"child" means a human from the beginning of life birth to the beginning of adulthood, and in the present invention, the age of childhood is 0-18 years, especially 0-14 years, 1-10 years, and 1-5 years.
In the invention, the functional food refers to food with specific nutrition and health care functions, namely food which is suitable for specific people to eat, has the function of adjusting organism and does not aim at treatment. Functional foods are sometimes also referred to as health food products.
The term "effective amount" refers to the amount that achieves treatment, prevention, alleviation and/or relief of a disease or condition of the present invention in a subject, which depends on a number of factors, including the age, weight, sex, natural health condition, nutritional condition, time of administration, metabolic rate, severity of the condition, and subjective judgment of the physician, etc., and therefore the invention is not particularly limited.
The terms "patient", "subject" are used interchangeably herein and refer to an animal, such as a mammal, particularly such as a human, and in particular a child, that receives the compositions and methods of the present invention to treat, prevent, ameliorate and/or alleviate a disease or disorder described herein.
The term "treating" includes eradicating, removing, reversing, alleviating, altering or controlling the disease or disorder after its onset.
The term "preventing" refers to the ability to prevent, minimize or make difficult the onset or progression of a disease or disorder by treatment prior to the onset of the disease or disorder.
The traditional Chinese medicines of the raw materials in the composition of the invention are well described in Chinese pharmacopoeia, chinese dictionary and Chinese herbal medicine, for example:
Herba Hedyotidis Diffusae is whole plant of herba Hedyotidis Diffusae Hedyotis diffusa Willd of Rubiaceae [ Oldenlandia diffusa (Willd.) ] Roxb; slightly bitter in taste and cold in nature; stomach, large intestine and small intestine channels; efficacy: clearing heat and detoxicating, removing dampness and treating stranguria; the processing method comprises the following steps: removing impurities and soil, and sun drying.
Gypsum Fibrosum, which is sulfate mineral anhydrite, contains mainly hydrous calcium sulfate (CaSO 4 ·2H 2 O), sweet and pungent in flavor, and cold in nature; enter lung and stomach meridians; efficacy: clearing heat and purging fire, relieving restlessness and quenching thirst; the processing method comprises the following steps: cleaning, drying, pulverizing, removing impurity stone, and pulverizing into coarse powder.
Rhizoma Phragmitis is fresh or dried rhizome of reed Phragmites communis Trin of Gramineae; sweet in taste and cold in nature; enter lung and stomach meridians; efficacy: clearing heat and promoting fluid production, relieving restlessness, stopping vomiting and promoting urination; the processing method comprises the following steps: removing impurities, cleaning, cutting or sun drying.
Herba Schizonepetae is dry aerial part of herba Schizonepetae Schizonepeta tenuifolia Briq. Of Labiatae; pungent taste and slightly warm nature; enter lung and liver meridians; efficacy: relieving exterior syndrome, dispelling pathogenic wind, promoting eruption; the processing method comprises the following steps: removing impurities, spraying clear water, cleaning, moistening, cutting, and sun drying.
Ramulus Uncariae cum Uncis is dry hooked stem branch of Uncaria rhynchophylla 0 phyla (Miq.) of Rubiaceae, jacks, uncaria macrophylla Uncaria macrophylla wall, uncaria tomentosa Havill, uncaria sinensis (Oliv.) Havil. Or Uncaria sessilifolia Uncaria sessilifructus Roxb; sweet in taste and cool in nature; meridian entered liver and pericardium; efficacy: clearing heat and calming liver, and stopping wind and convulsion; the processing method comprises the following steps: removing old stems and impurities, cleaning and sun drying.
Peppermint is the dry aerial part of peppermint Mentha haplocalyx Briq of the genus Mentha of the family Labiatae; pungent taste and cool nature; enter lung and liver meridians; efficacy: disperse wind-heat, clear head and eyes, promote eruption; the processing method comprises the following steps: removing old stems and impurities, slightly spraying clear water, slightly wetting, cutting into short sections, and timely drying at low temperature.
The technical solutions of the present invention will be clearly and completely described in conjunction with the embodiments of the present invention, and it is apparent that the described embodiments are only some embodiments of the present invention, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
Example 1: preparation of oral liquid
Formulation composition (i.e., the upper sense agent applied in example 3):
100g of oldenlandia diffusa, 100g of gypsum, 75g of reed rhizome, 30g of schizonepeta, 45g of uncaria and 30g of peppermint.
The preparation method comprises the following steps: decocting Gypsum Fibrosum in water for 30 min, adding herba Hedyotidis Diffusae and rhizoma Phragmitis into the decoction, decocting for 1 hr twice, filtering, mixing filtrates, concentrating to 300ml, decocting herba Schizonepetae, ramulus Uncariae cum Uncis and herba Menthae in water for 30 min twice, filtering, concentrating filtrate to 400ml, mixing with the above filtrate, adding 200ml of simple syrup and appropriate amount of ethyl hydroxybenzoate, adding water to 1000ml, mixing, packaging, sterilizing, and sealing.
The obtained product is brown liquid and sweet.
Example 2: analysis and identification of oral liquid
60ml of the liquid prepared in example 1 was taken and placed in a separating funnel, extracted twice with diethyl ether (20 ml,40 ml), the water layer was evaporated to dryness in water bath, and the residue was dissolved in 20ml of methanol and sonicated for 30 minutes, filtered, and the filtrate was concentrated to about 1ml as a test solution.
And adding methanol into oleanolic acid reference substance to obtain a solution containing 1mg per 1ml, and taking the solution as reference substance solution.
Thin layer chromatography (appendix VI B of 2005 edition of Chinese pharmacopoeia) test, the two solutions are respectively spotted on the same silica gel G plate, developed by using chloroform-acetone (95:5) as developing agent, taken out, dried in the air, sprayed with 5% sulfuric acid ethanol solution, and heated at 105 ℃ until the spots develop clearly. Spots with the same color are displayed on the corresponding positions of the chromatogram of the reference sample.
Example 3: clinical diagnosis and treatment of cases
The hospital in the children hospital in Jiangxi province, 2013, is plucked to diagnose and treat the children treatment cases as follows:
ID number/date of visit/prescription number/drug name/specification/quantity/diagnostic result
11140955/apply somewhere/2013/1/1:15:32:25/47712/upper sense agent/100 ml/1.00/bronchitis
11130039/Li certain/2013/1/5:16:34:03/89783/Shangganji/100 ml/1.00/acute pharyngitis
11143397/Zhang Mou 2013/1/5:17:14:27/90078/upper sense agent/100 ml/1.00/diaper rash (buttock erythema), bronchitis
11144704/Li certain/2013/1/7:19:56/11343/Shangganji/100 ml/1.00/acute pharyngitis
11145167/from 1/2013/1/8:10:44:28/19553/Shangganhe/100 ml/1.00/pharyngitis
11140676/Huqisome/2013/1/8:11:41:54/21125/Shangganhe/100 ml/1.00/bronchitis
10247975/grandchild/2013/1/9:25:52/34478/upper-feeling agent/100 ml/2.00/acute pharyngitis
11099261/Huqicertain/2013/1/9:11:43:31/34877/upper-respiratory-tract infection/100 ml/1.00/upper-respiratory-tract infection
11146194/Zhen somewhere/2013/1/9:25:58/37972/upper sensing agent/100 ml/1.00/upper respiratory tract infection
11146182/Huqicertain/2013/1/9:41:44/39527/Shangganji/100 ml/1.00/edema, acute pharyngitis
11113817/Huangxiao certain/2013/1/10:11:07:10/47583/upper airway infection/100 ml/4.00/upper airway infection
11073264/week 1/2013/1/10:11:19/47289/upper induction agent/100 ml/1.00/acute bronchiolitis
11042301/Lixisomebody/2013/1/10:51:04/48823/upper airway infection/100 ml/1.00/upper airway infection
11147282/Liu somewhere/2013/1/11:35:07/57404/Shangganhe/100 ml/1.00/bronchopneumonia
11147510/Qin certain/2013/1/11:51:32/60075/upper sensing agent/100 ml/1.00/upper respiratory tract infection
10528097/wang certain/2013/1/11:39:30/65064/upper induction agent/100 ml/3.00/respiratory tract infection
11124274/Xu Mou/2013/1/11:53:27/65363/upper airway infection/100 ml/1.00/upper airway infection
11148967/chapter somewhere/2013/1/13:29:56/86635/upper-respiratory-tract infection/100 ml/1.00/upper-respiratory-tract infection
11149145/Wuqi certain/2013/1/13:15:28/89291/Shangganhe/100 ml/1.00/acute pharyngitis
10431634/Huqicertain/2013/1/13:16:12/89273/Shangzhen/100 ml/2.00/granulocyte elevation, mumps
10888628/Liu somewhere/2013/1/15:14:59:41/19093/upper sense agent/100 ml/1.00/upper respiratory tract infection
11134704/Huqicertain/2013/1/16:11:58:42/31682/upper-sensing agent/100 ml/1.00/upper respiratory tract infection
11117367/Shenqi/2013/1/16:19:54/31988/upper airway infection/100 ml/1.00/upper airway infection
11151814/Aicertain/2013/1/16:28:13/35967/Shangganhe/100 ml/1.00/upper respiratory tract infection, rickets
11152264/Pengsomewhere/2013/1/17:13:38/45288/upper sense agent/100 ml/1.00/infectious fever
11152366/Lixisomebody/2013/1/17:16:19/46648/Shanggang mixture/100 ml/1.00/infant bronchitis
11037957/Jishi/2013/1/17:11:04/47679/Shangganji/100 ml/4.00/acute pharyngitis
11137410/Populus tomentosa/2013/1/17:11:54/47692/Shangganji/100 ml/4.00/acute pharyngitis
11008539/wang certain/2013/1/17:09:28/51202/Shangganji/100 ml/2.00/acute pharyngitis, upper respiratory infection
11097605/ certain/2013/1/18:17:10/56258/upper sense agent/100 ml/1.00/infant bronchitis
11152906/Song somewhere/2013/1/18:55:40/57632/upper respiratory tract infection/100 ml/1.00/upper respiratory tract infection, rickets
11153040/Hu Mou/2013/1/18:17:50/58325/Shangganhe/100 ml/1.00/acute pharyngitis
11153086/wang certain/2013/1/18:02:14/59631/Shangganhe/100 ml/1.00/bronchitis
11152649/Weathert/2013/1/18:15:56:28/62761/Shangganning mixture/100 ml/1.00/acute pharyngitis
11098309/Lixisomebody/2013/1/19:11:42:19/72162/Shangganhe/100 ml/3.00/acute bronchitis
11078027/xie somewhere/2013/1/19:49:13/73824/upper airway infection/100 ml/1.00/upper airway infection
10877705/Huqisome/2013/1/20:09:32/85877/Shangganhe/100 ml/1.00/bronchitis
10625134/Lixisomebody/2013/1/21:11:59:07/2582/upper-sensing agent/100 ml/1.00/upper respiratory tract infection
11114888/Chen somewhere/2013/1/22:08:11/12529/Shangganhe/100 ml/1.00/conjunctivitis
11156488/Huqicertain/2013/1/22:53:12/16836/upper airway infection/100 ml/2.00/acute upper airway infection
11156523/Wu certain/2013/1/22:11:32:37/17954/Shangganhe/100 ml/1.00/conjunctivitis
11157072/Qin certain/2013/1/23:30:56/28575/Shangganhe/100 ml/1.00/acute pharyngitis
11157470/Tang somewhere/2013/1/23:30:26/35228/upper sensing agent/100 ml/3.00/upper respiratory tract infection
11060626/permitted somebody/2013/1/23:00:26/38795/upper respiratory tract infection/100 ml/1.00/upper respiratory tract infection, rickets
11152045/bear some/2013/1/24:15:41:32/52285/upper induction agent/100 ml/1.00/acute pharyngolaryngitis, congenital heart disease
11139053/wang certain/2013/1/25:11:05:47/63145/Shangganji/100 ml/1.00/acute pharyngitis
11156488/Huqicertain/2013/1/25:53:50/64626/Shangganhe/100 ml/1.00/acute bronchitis
11032420/Huqicertain/2013/1/25:16:03:41/69500/upper-sensing agent/100 ml/1.00/upper respiratory tract infection
11085125/rusome/2013/1/26:17:33/83994/upper induction agent/100 ml/1.00/upper respiratory tract infection
10054633/Hesome/2013/1/27:10:02:56/90815/Shangganji/100 ml/3.00/acute pharyngitis
10986702/Dungcertain/2013/1/27:06:34/96994/upper airway infection/100 ml/1.00/upper airway infection
11161021/Li certain/2013/1/27:49:49/97907/Shangganhe/100 ml/1.00/jaundice, acute pharyngitis
11160872/what something/2013/1/27:16:24:46/98571/upper sense agent/100 ml/1.00/bronchitis
11140827/rotigong/2013/1/28:41:58/10684/upper sense agent/100 ml/1.00/acute bronchiolitis
11161816/Liu somewhere/2013/1/28:55:04/12590/Shangganhe/100 ml/1.00/acute pharyngitis
10371826/Liu Mou/2013/1/28:14:25:53/13250/Shangganhe/100 ml/2.00/acute pharyngitis
10839006/Liu somewhere/2013/1/28:14:38:27/13911/upper sense agent/100 ml/2.00/upper respiratory tract infection
11161780/Deng Mou/2013/1/28:43:20/14027/upper sense agent/100 ml/2.00/hydrocele of tunica vaginalis, scrotum infection
11163135/week-somewhere/2013/1/29:15:07/34575/upper-handicap/100 ml/1.00/infant bronchitis, bronchopneumonia
10982066/bear some/2013/1/30:11:48/42573/upper sense agent/100 ml/1.00/infectious fever
11163947/Liu somewhere/2013/1/30:50:12/46941/Shangganhe/100 ml/1.00/rash, upper respiratory tract infection
11161013/week 1/2013/1/31:11:05:22/65697/upper induction agent/100 ml/1.00/bronchopneumonia
11045183/Wu Mou/2013/2/2:11:20:16/113/upper airway infection agent/100 ml/2.00/bronchitis
10721180/Huqicertain/2013/2/2:15:23:12/3489/upper-sensing agent/100 ml/2.00/acute upper respiratory tract infection
11068879/Shuaisome/2013/2/2:15:30:22/3646/Shangganji/100 ml/1.00/Upper respiratory disease, dyspepsia, rickets
11168025/peri/2013/2/2 16:57:16/5253/upper induction agent/100 ml/5.00/acute pharyngitis
11168087/Qian somewhere/2013/2/2:20:28/6514/Shangganhe/100 ml/1.00/chronic rhinitis
10821586/Zhang Mou/2013/2/3:33:58/9793/Shangganhe/100 ml/1.00/acute tonsillitis
11081641/bear some/2013/2/3:15:57:49/18970/upper induction agent/100 ml/6.00/acute bronchitis, bronchopneumonia
11169443/Dusome/2013/2/4:27:43/28757/Shangganhe/100 ml/2.00/acute bronchitis
11170600/pay for 2013/2/5:54:28/46554/upper airway infection/100 ml/1.00/viral upper airway infection
11171091/wang certain/2013/2/5:08:43/53929/Shangganji/100 ml/2.00/acute pharyngitis
11062738/grandchild/2013/2/6:11:40/56970/upper-respiratory-tract infection/100 ml/5.00/acute upper-respiratory tract infection
11171413/Du certain/2013/2/6:30:41/59156/upper sensing agent/100 ml/1.00/viral upper respiratory tract infection
00425998/rotigong/2013/2/6 10:33:01/61488/upper sensing agent/100 ml/3.00/acute upper respiratory tract infection
11171570/Li certain/2013/2/6:11:16:21/63200/Shangganhe/100 ml/1.00/acute pharyngitis
11049555/Huangxiao certain/2013/2/6:11:16:24/63026/Shangganji/100 ml/1.00/acute pharyngitis
11148080/Zhang somewhere/2013/2/7:08:20/72669/upper-sensing agent/100 ml/1.00/acute upper respiratory tract infection
11172236/Condition somewhere/2013/2/7:38:56/73622/Shangganhe/100 ml/1.00/acute bronchitis
11164763/Bicertain/2013/2/7:09:00/74582/Shangganhe/100 ml/1.00/acute bronchiolitis
11172391/Jiang somewhere/2013/2/7:55:44/76018/upper airway infection/100 ml/1.00/acute upper airway infection
11165778/Lixisomebody/2013/2/7:14:00/77716/Shangganhe/100 ml/2.00
11156523/Wu certain/2013/2/7:52:28/80756/Shangganhe/100 ml/2.00/acute upper respiratory tract infection
10125380/Chen Jicertain/2013/2/7:12:02/81018/Shangganhe/100 ml/4.00/acute pharyngitis
11173101/Huqicertain/2013/2/8:11:04:56/88042/Shangganhe/100 ml/1.00/acute upper respiratory tract infection
11173932/bear some/2013/2/10:42:28/2744/upper sense mixture/100 ml/1.00/acute pharyngitis
11176272/what should be/2013/2/14:13:24/40811/upper induction agent/100 ml/1.00/acute pharyngitis
11178829/Zhen certain/2013/2/17:46:22/79243/Shang Gang Ji/100 ml/1.00/acute upper respiratory tract infection
11179839/innocent somewhere/2013/2/18:55:15/93865/upper induction agent/100 ml/1.00/acute bronchitis
10741471/Lixisome/2013/2/18:16:36:57/699/Shangganji/100 ml/1.00/acute pharyngitis
11182225/Rainbow/2013/2/20:15:32:16/27772/upper-sensing agent/100 ml/1.00/acute upper respiratory tract infection
11185088/horse certain/2013/2/23:04:47/72942/upper induction agent/100 ml/2.00/bronchopneumonia
10488568/Xusome/2013/2/24:49:47/79293/Shangganhe/100 ml/1.00/acute tonsillitis
11188608/Zhen certain/2013/2/27:11:46:51/27397/upper-sensing agent/100 ml/1.00/acute upper respiratory tract infection
11122410/xie somewhere/2013/2/28:9:36:22/38282/upper-sensing agent/100 ml/1.00/acute upper respiratory tract infection
10534211/Hesome/2013/2/28:38:15/45945/Shangganhe/100 ml/4.00/acute tonsillitis
11189749/Tian Mou/2013/2/28:16:31:42/47111/upper respiratory tract infection/100 ml/1.00/acute upper respiratory tract infection, rickets
11182892/Tian Mou/2013/2/28:31:54/46969/upper respiratory tract infection/100 ml/1.00/acute upper respiratory tract infection, rickets
11144639/Yuan certain/2013/3/1:22:41/53677/Shangganhe/100 ml/4.00/acute pharyngitis
11190764/Li certain/2013/3/1:11:17/61802/upper sensing agent/100 ml/1.00/acute upper respiratory tract infection
10839781/Song somewhere/2013/3/4:09:53/92169/upper airway infection/100 ml/2.00/acute upper airway infection
10839006/Liu somebody/2013/3/4:06:11/94771/Shangganhe/100 ml/2.00/acute pharyngitis, rickets
11095958/Zhang somewhere/2013/3/4 10:49:29/98443/Shanggang mixture/100 ml/1.00/chronic dacryocystitis
11108836/from 1/2013/3/4:15:41:54/6099/upper-respiratory-tract infection/100 ml/4.00/acute upper respiratory tract infection
11191660/rotigong/2013/3/4:42:40/6103/upper sensing agent/100 ml/1.00/acute upper respiratory tract infection
11193571/Lixisomebody/2013/3/4:16:36:20/7282/upper induction agent/100 ml/1.00/indirect inguinal hernia, acute upper respiratory infection
11148605/ certain/2013/3/5:22:00/22431/upper airway infection/100 ml/1.00/acute upper airway infection
11156432/chen somewhere/2013/3/6:52:12/29180/Shangganhe/100 ml/3.00/acute pharyngitis
11195052/Huangxiao certain/2013/3/6:40:59/31231/Shangganji/100 ml/1.00/acute bronchitis
11145477/Zhang certain/2013/3/6:35:04/35092/upper sense agent/100 ml/1.00/dysplasia
11114888/Chen somewhere/2013/3/8:28:09/62745/Shangganhe/100 ml/1.00/conjunctivitis
11187335/chapter somewhere/2013/3/8:57:44/66444/upper-respiratory-tract infection/100 ml/1.00/acute upper-respiratory tract infection
00000260/Liu somewhere/2013/3/11:57:57/3452/Shangganhe/100 ml/10.00
11200784/Xiacertain/2013/3/11:11:11:02/23136/Shangganhe/100 ml/1.00/bronchitis
11197983/child certain/2013/3/11:36:21/26109/upper induction agent/100 ml/1.00/acute pharyngitis
11026556/Pengsomewhere/2013/3/11:34:45/27771/Shangganji/100 ml/1.00/acute pharyngitis
11195839/Jiang somewhere/2013/3/11:09:30/28446/Shangganji/100 ml/1.00/acute pharyngitis
10900391/should someone/2013/3/13:16:32:57/62765/upper-sensing agent/100 ml/1.00/acute upper respiratory tract infection
00000391/Chen Mou/2013/3/14:20:43/6534/upper-sense agent/100 ml/3.00
11073322/Moxiao certain/2013/3/15:10:39:54/86920/Shangganhe/100 ml/2.00/bronchitis
10917683/Mei Ji certain/2013/3/16:44:01/5518/Shangganhe/100 ml/1.00/bronchitis
10905237/Zhang somewhere/2013/3/16:17:02:02/9564/Shangganhe/100 ml/1.00/acute pharyngitis
11171819/Hu Mou/2013/3/17:23:06/18942/Shangganhe/100 ml/1.00/bronchitis
11170419/Gong's certain 2013/3/18:06:26/30934/Shangganhe/100 ml/1.00/bronchitis
11207209/Lixisomebody/2013/3/18:53:57/32537/Shanggang agent/100 ml/1.00/acute bronchiolitis
11168955/Pengsomewhere/2013/3/18:44:17/39354/Shangganji/100 ml/1.00/acute pharyngitis
11208761/wang certain/2013/3/19:15:35:55/55626/Shangganji/100 ml/1.00/acute pharyngitis
11209234/Taozhi/2013/3/20:43:00/66103/Shangganji/100 ml/1.00/acute pharyngitis
11209332/Lixisomebody/2013/3/20:11:21:14/67370/upper-sensing agent/100 ml/1.00/acute upper respiratory tract infection
11209995/what should be/2013/3/21 10:05:01/79390/upper sense agent/100 ml/1.00/prostatic nodule
11211025/ certain/2013/3/22:09:05/94872/Shangganhe/100 ml/1.00/bronchitis
11211555/Deng Mou/2013/3/22:16:46:41/3046/upper induction agent/100 ml/3.00/acute pharyngitis
11211772/clock/2013/3/23:14:53/6100/upper sense agent/100 ml/6.00/bronchitis
11211793/bear some/2013/3/23:34:02/8658/upper sense agent/100 ml/1.00/infectious fever
11053242/Lun somewhere/2013/3/23:52:31/16281/upper airway infection/100 ml/1.00/acute upper airway infection
11061007/Lin certain/2013/3/23:57:42/16437/Shangganhe/100 ml/1.00/Upper respiratory disease, rickets
11213556/bear some/2013/3/25:10:16:57/38816/upper induction agent/100 ml/1.00/acute upper respiratory tract infection, rickets
11182454/journey someone/2013/3/25:10:41:11/39572/upper induction agent/100 ml/1.00/acute upper respiratory tract infection
11026534/Chen somewhere/2013/3/25:10:59:56/40697/Shangganhe/100 ml/1.00/infectious fever, acute pharyngitis
11213848/bear some/2013/3/25:12:10:22/43043/upper sense agent/100 ml/1.00/bronchopneumonia
11089162/apply somewhere/2013/3/27:10:51:18/70913/upper sense agent/100 ml/1.00/infectious fever
11216018/rotigong/2013/3/27:16:59:41/78587/upper sense agent/100 ml/1.00/prostatic nodule
11217638/Zhou Mou/2013/3/29:25:17/1343/Shangganhe/100 ml/4.00/acute pharyngitis
11174658/fan somewhere/2013/4/1:10:40:36/47525/upper-respiratory-tract infection/100 ml/1.00/acute upper-respiratory tract infection
10839781/Song Mou/2013/4/1:44:03/54863/upper airway infection/100 ml/2.00/acute upper airway infection
10873171/operating someone/2013/4/2 10:37:05/64903/upper sense agent/100 ml/1.00/bronchitis
11221658/Chen-some/2013/4/2:11:47:38/67786/Shangganhe/100 ml/1.00/acute lower respiratory tract infection, bronchopneumonia
11222089/Wu certain/2013/4/2:18:10:24/73049/Shangganhe/100 ml/2.00/acute upper respiratory tract infection, acute pharyngitis
11222731/Chen Jicertain/2013/4/3:55:00/84605/Shangganhe/100 ml/1.00/acute pharyngitis
11215854/Wei certain/2013/4/3:57:23/86757/upper sense agent/100 ml/1.00/bronchopneumonia
11194506/somewhere/2013/4/5:10:51:46/94753/upper sense mixture/100 ml/1.00/nausea and vomiting, acute pharyngitis, auditory nerve injury
10965107/wanqi/2013/4/5:11:32:15/10479/Shangganji/100 ml/1.00/acute pharyngitis
11180343/Liu somebody/2013/4/5:55:17/15174/Shangganhe/100 ml/1.00/acute upper respiratory tract infection, rickets
11193075/Guo certain/2013/4/7:46:01/38006/upper induction agent/100 ml/1.00/acute upper respiratory tract infection
00822352/Sunzhixiao/2013/4/7:34:38/41968/Shangganji/100 ml/2.00/acute tonsillitis
11226305/Lixisomebody/2013/4/7:01:36/42349/Shangganhe/100 ml/1.00/bronchitis
10703336/Guqicertain/2013/4/7:50:37/48059/Shangganhe/100 ml/2.00/bronchitis
11227747/week 1/2013/4/8:15:46:44/62905/Shangganhe/100 ml/5.00/acute pharyngitis
11228762/Populus tomentosa/2013/4/9:02:37/79742/upper induction agent/100 ml/1.00/acute upper respiratory tract infection
11226121/what is/2013/4/10:11:02:25/90741/upper sensing agent/100 ml/1.00/ventricular septal defect
11213550/Tianxiao/2013/4/11:13:02/3183/Shangganhe/100 ml/1.00/acute tonsillitis
10034315/Tao Mou/2013/4/11:45:14/10815/upper induction agent/100 ml/1.00/congenital heart disease
11230877/Chua somebody/2013/4/11:30:46/13598/Shangganhe/100 ml/1.00/acute pharyngitis
11197122/Zhou certain/2013/4/12:53:38/18901/Shangganhe/100 ml/1.00/acute tonsillitis
11045183/Wu Mou/2013/4/16:10:48:39/92310/Shangganhe/100 ml/2.00/acute pharyngitis
11236702/Zhou certain/2013/4/17:46:51/13321/upper induction agent/100 ml/1.00/upper respiratory disease, rickets
11156806/Wu certain/2013/4/18:11:18/28488/Shangganhe/100 ml/1.00/congenital heart disease
11180709/Xuexisomecertain/2013/4/19:10:39:15/38862/upper induction agent/100 ml/1.00/viral upper respiratory tract infection
11153816/Zhang certain/2013/4/19:15:01:05/43632/Shangganji/100 ml/2.00/acute pharyngitis
10877705/Huqisome/2013/4/20:10:40:29/53227/Shangganhe/100 ml/2.00/acute tonsillitis
11239586/Shoucertain/2013/4/20:45:24/59110/Shangganji/100 ml/1.00/acute upper respiratory tract infection
11241628/wang certain/2013/4/22:21:12/91155/Shangganji/100 ml/2.00/enterovirus infection, acute pharyngitis
00427778/Lixisomebody/2013/4/23:13:23/4668/upper sense agent/100 ml/2.00/indirect inguinal hernia, acquired trunk deformity
11243303/bear some/2013/4/24:16:19:00/19349/upper induction agent/100 ml/1.00/upper respiratory disease, dyspepsia, rickets
11243879/Chen somewhere/2013/4/25:10:21:40/27127/Shangganhe/100 ml/1.00/acute upper respiratory tract infection
11243884/Dusome/2013/4/25:39:12/28321/upper-respiratory-tract infection/100 ml/1.00/acute upper-respiratory tract infection
11230134/Gong's certain/2013/4/25:14:52:41/32347/Shangganhe/100 ml/1.00/acute bronchitis
11244290/Gaobao/2013/4/25:16:12:27/34303/Upper sensing agent/100 ml/1.00/viral upper respiratory tract infection
11245111/Lixisome/2013/4/26:41:18/47219/Shangganji/100 ml/1.00/acute pharyngitis
11232894/Zhou certain/2013/4/27:11:16:19/60289/Shangganhe/100 ml/1.00/acute pharyngitis
10054633/some other/2013/4/30 11:17:29/12462/Shangganji/100 ml/3.00/acute pharyngitis, precocious puberty, bronchitis
11251564/bear some/2013/5/2 10:43:54/44503/Shangganhe/100 ml/2.00/acute pharyngitis
11251777/Hesome/2013/5/2:15:42/47513/Shangganhe/100 ml/5.00/acute pharyngitis
10644074/ginger somebody/2013/5/2:13:21:52/48926/upper induction agent/100 ml/3.00/acute suppurative otitis media
10416893/Liu somewhere/2013/5/3:39:46/57927/Shangganhe/100 ml/2.00/acute tonsillitis
11158194/Luo Mou/2013/5/8:11:02:05/54721/upper sense agent/100 ml/1.00/acute bronchiolitis
11227301/bear some/2013/5/9:53:18/76332/upper sense mixture/100 ml/1.00/acute pharyngitis
11260722/Huangxiao certain/2013/5/10:21:42/86585/Shangganhe/100 ml/1.00/acute upper respiratory tract infection
11260619/Zhen certain/2013/5/10:24:23/86476/upper sensing agent/100 ml/1.00/viral upper respiratory tract infection
11244424/rotigong/2013/5/10:11:17:44/88423/upper sensing agent/100 ml/1.00/acute upper respiratory tract infection
10793928/peri/2013/5/12:06:36/26904/upper induction agent/100 ml/2.00/acute pharyngitis
11263989/Yin certain/2013/5/13:25:22/38849/Shangganhe/100 ml/1.00/acute pharyngitis
11194811/Lixisomebody/2013/5/13:20:21/49314/Shangganji/100 ml/1.00/acute pharyngolaryngitis
11267713/Huqicertain/2013/5/16:02:24/96744/upper-sensing agent/100 ml/1.00/acute upper respiratory tract infection
11267981/Xu Mou/2013/5/17:09:59/9279/upper airway infection/100 ml/1.00/acute upper airway infection
11270235/che certain/2013/5/19:11:22/42854/Shangganhe/100 ml/1.00/acute upper respiratory tract infection, rickets
11270670/scribble some/2013/5/19:48:58/46878/upper induction agent/100 ml/2.00/acute upper respiratory tract infection, heart murmur
11271303/Xusome/2013/5/20:48:05/55541/Shangganhe/100 ml/1.00/bronchitis
11115365/wang certain/2013/5/22:48:18/96463/Shangganji/100 ml/1.00/acute pharyngitis
11276097/Xie Mou/2013/5/24:27:01/27898/Shangganhe/100 ml/1.00/acute pharyngitis
00806163/Xuesome/2013/5/25:19:10:51/49296/upper-sensing agent/100 ml/3.00/acute upper respiratory tract infection
10452228/Lixisomebody/2013/5/26:11:19:09/58813/upper-sensing agent/100 ml/1.00/acute upper respiratory tract infection
11270467/Xiacertain/2013/5/27:17:08/72381/Shangganhe/100 ml/1.00/acute pharyngitis
11285747/Zhengsomewhere/2013/6/3:46:55/83224/Shangganhe/100 ml/1.00/acute pharyngitis, rickets
11108836/from 1/2013/6/3:10:44:37/90464/upper airway infection/100 ml/3.00/acute upper airway infection
11286887/somewhere left/2013/6/4:56:59/17272/upper airway infection agent/100 ml/1.00/sepsis
11289038/week-somewhere/2013/6/5:20:11/37204/Shangganji/100 ml/1.00/febrile, acute pharyngitis
11179793/Hesome/2013/6/7:24:20/70732/Shangganhe/100 ml/1.00/acute pharyngitis
10875779/Min somewhere/2013/6/8:16:45:12/84609/Shangganhe/100 ml/1.00/acute pharyngitis
11179793/Hesome/2013/6/8 22:23:08/86771/Shangganhe/100 ml/1.00/acute pharyngitis
11280032/Liu somewhere/2013/6/12:14:47:37/41853/Shangganhe/100 ml/1.00/acute pharyngitis
11295397/nie certain/2013/6/12:04:50/43251/Shangganhe/100 ml/1.00/acute pharyngitis
11295490/wang certain/2013/6/12:27:25/44636/upper airway infection agent/100 ml/1.00/sepsis
11190438/about some 2013/6/14:26:16/67484/upper sense agent/100 ml/1.00/sepsis
11297877/Chen Jicertain/2013/6/14:43:31/79219/Shangganhe/100 ml/1.00/acute pharyngitis
10965463/bear some/2013/6/14:16:10:35/80056/upper sense mixture/100 ml/1.00/acute pharyngitis
11044229/Lixisomebody/2013/6/14:20:36:01/82455/Shangganji/100 ml/4.00/acute pharyngitis, bronchitis
11299009/Maozi/2013/6/15:06:43/96548/Shangganhe/100 ml/3.00/acute upper respiratory tract infection, bronchitis
11301774/wang certain/2013/6/18:9:19:59/39786/upper-sensing agent/100 ml/1.00/acute upper respiratory tract infection
11294314/Xusome/2013/6/19:11:54:12/62796/Shangganji/100 ml/1.00/acute pharyngitis
11303471/von somewhere/2013/6/19:29:47/68585/upper-sense mixture/100 ml/3.00/acute upper respiratory tract infection, acute pharyngitis
10847110/Dong somewhere/2013/6/20:28:53/84555/upper-sensing agent/100 ml/6.00/acute upper respiratory tract infection
11297288/Li certain/2013/6/21:11:05:58/94353/Shangganji/100 ml/1.00/acute pharyngitis
11062738/Sunzhixiao/2013/6/22:56:31/14003/Shangganji/100 ml/4.00/acute tonsillitis
11103354/Min somewhere/2013/6/23:16:39:24/29765/Shangganhe/100 ml/1.00/acute pharyngitis
11303790/xie somewhere/2013/6/24:25:36/39548/Shangganhe/100 ml/1.00/acute bronchitis
11288915/Bian/2013/6/24:42:41/40833/Shangganhe/100 ml/1.00/acute pharyngitis
11156956/wang certain/2013/6/24:57:05/47185/Shangganji/100 ml/1.00/acute pharyngitis
11311195/Gong's certain/2013/6/27:47:11/90082/upper sense agent/100 ml/2.00/respiratory disease
11311199/Chua somebody/2013/6/27:52:41/90247/upper sense agent/100 ml/2.00/respiratory disease
11188108/what should be/2013/6/28:23:37/14891/upper induction agent/100 ml/1.00/acute pharyngitis
10879457/Zhongcertain/2013/6/28:17:20:55/20679/Shangganhe/100 ml/2.00/congenital heart disease
11313716/Feng Mou/2013/6/29:53:22/30915/upper airway infection/100 ml/2.00/acute upper airway infection, acute pharyngitis
11316449/Guiqi/2013/7/2 10:01:24/81691/upper induction agent/100 ml/1.00/septicemia, bronchitis
11320302/Xiacertain/2013/7/4:17:01/29192/Shangganhe/100 ml/1.00/acute upper respiratory tract infection
11320761/ certain/2013/7/4 18:03:49/35541/upper induction agent/100 ml/4.00/acute pharyngitis
11226048/Wang somewhere/2013/7/7:9:09:37/77208/Shangganhe/100 ml/1.00/acute pharyngitis
11323313/what should be/2013/7/7:9:20:15/77593/Shangganhe/100 ml/1.00/acute pharyngitis
11091667/Li certain/2013/7/7:12:02:06/83135/Shangganji/100 ml/1.00/acute pharyngitis
11077116/Jiang somewhere/2013/7/8:15:19:58/5385/Shangganji/100 ml/5.00/acute pharyngitis
11324146/Pan Mou/2013/7/8:20:10/5397/upper sense mixture/100 ml/1.00/acute tonsillitis
11329134/wang certain/2013/7/11:33:30/64476/upper airway infection/100 ml/1.00/acute upper airway infection
10946980/poplar somebody/2013/7/12:37:24/76615/upper induction agent/100 ml/2.00/acute upper respiratory tract infection, rickets
10839781/Song Mou/2013/7/15:19:04/17243/Shangganhe/100 ml/2.00/acute pharyngitis
11259912/Liu somewhere/2013/7/15:21:19/26490/Shangganhe/100 ml/1.00/acute pharyngitis
11335847/Zhucertain/2013/7/17:36:38/70237/Shangganhe/100 ml/1.00/acute pharyngitis
11337548/Hu Mou/2013/7/19:23:48/2668/upper-sensing agent/100 ml/2.00/acute upper respiratory tract infection
11338120/Gu Mou/2013/7/19:16:49:43/7314/upper induction agent/100 ml/1.00/acute pharyngitis
11338170/Dungcertain/2013/7/19:56:48/7916/Shangganhe/100 ml/1.00/acute pharyngitis
11227828/week 1/2013/7/22:11:18:06/49306/Shangganhe/100 ml/1.00/acute pharyngitis
11341764/Zhang Mou/2013/7/23:45:40/63758/upper airway infection/100 ml/1.00/acute upper airway infection
11317785/Jiang somewhere/2013/7/23:26:41/68004/Shanggang mixture/100 ml/2.00/acute upper respiratory tract infection
11343546/wang certain/2013/7/24:43:18/92598/Shangganji/100 ml/1.00/acute pharyngitis
11345224/Zhen certain/2013/7/26 11:51:57/21825/Shangganhe/100 ml/1.00/acute upper respiratory tract infection
11342577/Zhu somewhere/2013/7/30:11:14:37/84891/Shangganhe/100 ml/1.00/Special examination
11273824/week 1/2013/8/3:07:18/55922/upper induction agent/100 ml/1.00/acute pharyngitis
11251777/Hesome/2013/8/4:18:22/69980/Shangganhe/100 ml/2.00/acute pharyngitis
11346611/Yao certain/2013/8/5:17:39/75082/Shangganhe/100 ml/1.00/acute pharyngitis
11355272/Lixisomebody/2013/8/5:21:12/75570/Shangganji/100 ml/1.00/constipation
11135583/Chapter somewhere/2013/8/5:32:48/86038/Shangganji/100 ml/1.00/acute pharyngitis
11355974/Gong's girl/2013/8/5:09:42/86946/Shangganning mixture/100 ml/1.00/bronchitis
11357552/Weather/2013/8/7:30:29/13532/Shangganhe/100 ml/1.00/abdominal pain, dyspepsia
11207462/bear some/2013/8/7:08:31/15115/upper body feeling agent/100 ml/1.00/acute pharyngitis
11357878/fan somewhere/2013/8/7:21:51/15865/upper-sensing agent/100 ml/1.00/acute upper respiratory tract infection
11358247/somewhere/2013/8/7:37:21/24105/upper-respiratory-tract infection/100 ml/1.00/viral upper-respiratory-tract infection
11355376/Zhen certain/2013/8/8:11:38:04/35870/upper-sensing agent/100 ml/1.00/acute upper respiratory tract infection
11355622/Huang Mou/2013/8/12:01:19/90228/Shangganhe/100 ml/1.00/bronchitis
11362692/nie certain/2013/8/12:23:28/93756/Shangganhe/100 ml/1.00/acute bronchiolitis
11362982/Dungcertain/2013/8/12:00:06/98331/Shangganhe/100 ml/1.00/febrile, acute pharyngitis
11367358/Chen somewhere/2013/8/16:18:03:24/66352/Shangganhe/100 ml/3.00/acute upper respiratory tract infection
10848507/wang certain/2013/8/24:30:40/76170/Shangganhe/100 ml/4.00/bronchitis
11310923/Chen Jicertain/2013/8/28:09:52/46841/Shangganhe/100 ml/2.00/acute pharyngitis
10266731/Moxiao certain/2013/8/30:20:24:24/94019/Shangganhe/100 ml/1.00/acute tonsillitis
11387297/Liu somewhere/2013/9/6:12:15/86334/Shangganhe/100 ml/1.00/acute pharyngitis
11122755/Wu Mou/2013/9/6:18:59/90728/upper airway infection/100 ml/1.00/acute upper airway infection
11390701/Lisomebody/2013/9/12:27:43/76078/upper induction agent/100 ml/1.00/acute upper respiratory tract infection, congenital heart disease
11317665/Liu somewhere/2013/9/14:10:36:01/8981/upper sensing agent/100 ml/1.00/acute upper respiratory tract infection
11399217/about some/2013/9/19 10:39:15/91102/Shangganhe/100 ml/1.00/acute pharyngitis
11402972/Chen Jicertain/2013/9/22:21:54/47391/Shangganhe/100 ml/1.00/acute pharyngitis
10703336/Guqicertain/2013/9/26:48:46/5339/Shangganhe/100 ml/2.00/acute tonsillitis
11407746/Huqicertain/2013/9/27:22:14/27677/Shangganhu/100 ml/1.00/tibial fracture
11386901/Saint/2013/9/28:46:04/44822/Shangganhe/100 ml/2.00/acute nasopharyngitis
11409397/from somewhere/2013/9/29 10:32:00/54306/Shangganhe/100 ml/1.00/acute pharyngitis
11337843/Mei Ji certain/2013/9/30:10:44:11/70673/Shangganhe/100 ml/4.00/acute upper respiratory tract infection
11020149/lan certain/2013/10/1:27:47/85633/Shangganhe/100 ml/1.00/acute upper respiratory tract infection, rickets
10747329/Xusome/2013/10/1:42:20/91039/Shangganhe/100 ml/1.00/nutritional anemia, rickets
10054633/somewhere else/2013/10/2:15:04:23/6019/Shangganhe/100 ml/1.00/acute pharyngitis, central precocity
10431634/Huqisome/2013/10/4:22:18/45736/Shangganhe/100 ml/2.00/acute tonsillitis
10796044/Hesome/2013/10/8:14:51/4833/Shangganhe/100 ml/4.00/acute pharyngitis
11325855/somewhere/2013/10/11:16:17/61010/upper sense agent/100 ml/1.00/tracheobronchitis, precocious puberty
11426125/Zhengsomewhere/2013/10/15:39:15/26052/upper induction agent/100 ml/3.00/acute upper respiratory tract infection, dyspepsia
11390303/wang certain/2013/10/17:16:17:05/66381/Shangganji/100 ml/1.00/acute pharyngolaryngitis
11226271/Guo certain/2013/10/19:47:04/96425/Shangganhe/100 ml/1.00/acute pharyngitis
10986781/dropoff/2013/10/19:27:52/1569/Shangganji/100 ml/6.00/acute pharyngitis
11432015/Zhou certain/2013/10/21:34:29/34745/Shangganhe/100 ml/4.00/acute pharyngitis
08315141/included somewhere/2013/10/21:16:32:40/35953/upper-respiratory-agent/100 ml/2.00/acute upper respiratory tract infection, premature infant
08305972/leaf somewhere/2013/10/22:14:46:50/51881/upper-sensing agent/100 ml/1.00/acute upper respiratory tract infection
08310597/journey someone/2013/10/23:04:08/64399/upper induction agent/100 ml/1.00/acute upper respiratory tract infection
11320761/ certain/2013/10/24:11:46:45/86439/upper-sensing agent/100 ml/3.00/acute upper respiratory tract infection
08308745/Huqicertain/2013/10/27:16:41:59/46197/upper-sensing agent/100 ml/2.00/acute upper respiratory tract infection
11283135/Mei Ji certain/2013/10/27:16:20/47993/Shangganhe/100 ml/1.00/acute pharyngitis
08321573/Cao Mou/2013/10/30:32:45/99369/Shangganhe/100 ml/1.00/jaundice, acute pharyngitis
08329445/Lei certain/2013/10/30:14:05/5716/Shangganhe/100 ml/1.00/acute pharyngitis
11432671/Liu somewhere/2013/10/31:11:32:02/19464/Shangganhe/100 ml/1.00/acute pharyngitis
11295545/Wang Mou/2013/11/1:30:19/33432/upper respiratory tract infection/100 ml/1.00/acute upper respiratory tract infection, rickets
08308549/decoction of certain/2013/11/1:14:35/36314/upper-body mixture/100 ml/1.00/congenital heart disease, bronchopneumonia
10054633/some other/2013/11/3:14:31:34/71843/Shangganji/100 ml/3.00/acute pharyngitis, precocious puberty
08295619/Xuesome/2013/11/4:23:34/86481/upper sense agent/100 ml/1.00/neonatal skin infection
11426062/Dungcertain/2013/11/5:34:59/3375/Shangganhe/100 ml/1.00/acute pharyngitis
08322905/Xusome/2013/11/9:59:29/66120/Shangganhe/100 ml/1.00/upper respiratory disease, rickets
100005999/fujia/2013/11/12:03:20/9571/Shangganhe/100 ml/1.00/bronchitis
08284225/danger something/2013/11/13:42:15/23647/upper sense mixture/100 ml/1.00/acute pharyngitis
11397838/Wei certain/2013/11/15:28:47/48741/Shangganhe/100 ml/1.00/acute pharyngitis
11339780/Lixisomebody/2013/11/17:09:43/71121/upper-sensing agent/100 ml/1.00/acute upper respiratory tract infection
11047516/Zhongcertain/2013/11/19:16:14:32/1770/Shangganhe/100 ml/2.00/acute tonsillitis
11320761/ certain/2013/11/19:44:21/2311/upper-sensing agent/100 ml/4.00/acute upper respiratory tract infection
11348566/Lixisomebody/2013/11/20:51:50/12476/upper airway infection/100 ml/1.00/acute upper airway infection, vitamin D deficiency
100010269/Huqicertain/2013/11/21:27:08/19528/upper-sensing agent/100 ml/1.00/acute upper respiratory tract infection
11429017/xie somewhere/2013/11/21:15:36:52/27941/Shangganji/100 ml/1.00/acute pharyngolaryngitis, eczema
100042295/bear certain/2013/11/24:23:27/66864/upper induction agent/100 ml/1.00/acute upper respiratory tract infection
00000543/rotcertain/2013/11/25 14:58:39/5568/upper sense agent/100 ml/2.00
100014770/Lisome/2013/11/28 9:59:55/14057/Shangganji/100 ml/1.00/acute pharyngitis, neonatal fever, neonatal omphalia, infantile diarrhea
100040237/chapter somewhere/2013/11/30:35:03/44755/upper induction agent/100 ml/1.00/viral upper respiratory tract infection, rickets
10503132/Shifting somewhere/2013/12/2 16:05:25/72311/Shangganhe/100 ml/5.00/acute upper respiratory tract infection
100019686/some of the ways/2013/12/2 16:06:10/72319/Shangganhe/100 ml/3.00/acute pharyngitis
100007727/Pei Mou/2013/12/3:11:23:20/82235/Shangganhe/100 ml/1.00/bronchitis
11308434/Zhen certain/2013/12/9:56:20/68512/Shangganhe/100 ml/2.00/acute upper respiratory tract infection
The symptoms of the patients are improved and healed after the treatment.
The foregoing description of the preferred embodiments of the invention is not intended to be limiting, but rather is to be construed as including any modifications, equivalents, and alternatives falling within the spirit and principles of the invention.
The foregoing embodiments and methods described in this invention may vary based on the capabilities, experience, and preferences of those skilled in the art.
The listing of the steps of a method in a certain order in the present invention does not constitute any limitation on the order of the steps of the method.
Claims (8)
1. The composition is prepared from the following traditional Chinese medicine raw materials in parts by weight: 100 parts of oldenlandia diffusa, 100 parts of gypsum, 75 parts of reed rhizome, 30 parts of schizonepeta, 45 parts of uncaria and 30 parts of mint;
the composition is a mixture or syrup, and the preparation method comprises the following steps:
(1) Decocting Gypsum Fibrosum in water;
(2) Adding oldenlandia diffusa and reed rhizome into the decoction obtained in the step (1), decocting and filtering;
(3) Decocting herba Schizonepetae, ramulus Uncariae cum Uncis, and herba Menthae in water, and filtering;
(4) And (3) combining the filtrates obtained in the steps (2) and (3).
2. The composition of claim 1, wherein step (4) further comprises the step of adding a pharmaceutically acceptable excipient.
3. The composition of claim 2, wherein the adjuvant comprises syrup and/or a preservative.
4. Use of a composition according to any one of claims 1 to 3 for the preparation of a medicament for the prophylaxis and/or treatment of respiratory tract infections.
5. The use according to claim 4, wherein the respiratory tract infection is selected from the group consisting of: common cold, rhinitis, pharyngitis, laryngitis, tonsillitis, tracheitis, bronchitis and pneumonia.
6. The use according to claim 4, wherein the respiratory tract infection is an acute respiratory tract infection.
7. The use according to any one of claims 4-6, wherein the patient suffering from respiratory tract infection is a child.
8. The use according to any one of claims 4 to 6, wherein the patient suffering from respiratory tract infection is a child aged 1 to 5 years.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011170655.5A CN114404527B (en) | 2020-10-28 | 2020-10-28 | Traditional Chinese medicine composition for treating respiratory tract infection |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202011170655.5A CN114404527B (en) | 2020-10-28 | 2020-10-28 | Traditional Chinese medicine composition for treating respiratory tract infection |
Publications (2)
Publication Number | Publication Date |
---|---|
CN114404527A CN114404527A (en) | 2022-04-29 |
CN114404527B true CN114404527B (en) | 2024-02-20 |
Family
ID=81260391
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202011170655.5A Active CN114404527B (en) | 2020-10-28 | 2020-10-28 | Traditional Chinese medicine composition for treating respiratory tract infection |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN114404527B (en) |
-
2020
- 2020-10-28 CN CN202011170655.5A patent/CN114404527B/en active Active
Non-Patent Citations (4)
Title |
---|
中医治疗小儿上感160例疗效分析;王传吉等;《新中医》;19801231(第2期);第30-31页 * |
施今墨先生毕生用药经验(附有记忆口诀);天地阴阳;《https://www.sohu.com/na/380650671_488272》;20200317;第1-8页,尤其是第4页方37 * |
易磊.防胜于治:怎么做才能让孩子不感冒.《让孩子不上火不感冒不咳嗽不厌食》.上海科学技术文献出版社,2015,(第1版),第87-89页. * |
近期流感凶猛,家里常备这些药,90%的儿童感冒不需要去医院就诊!;东莞儿童网;《https://www.sohu.com/a/286612711_370859》;20190104;第1-22页,尤其是第19-20页 * |
Also Published As
Publication number | Publication date |
---|---|
CN114404527A (en) | 2022-04-29 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU2520745C2 (en) | Therapeutic composition for treating bronchitis and method for preparing it | |
US10105408B2 (en) | Traditional Chinese medicine composition and preparation method and use thereof | |
KR101262870B1 (en) | A composition comprising extract of Polygoni cuspidati Radix for treating or preventing respiratory disease | |
CN111298043A (en) | Traditional Chinese medicine composition for treating type 2 diabetes | |
KR20140131409A (en) | Composition comprising complex extract of Astragalus membranaceus BUNGE, Saposhnikovia divaricata Schiskin, Ostericum koreanum Maximowicz, Scutellaria baicalensis Georgi and Atractylodes japonica Koidz for preventing or treating asthma, bronchitis or pneumonia | |
CN114404527B (en) | Traditional Chinese medicine composition for treating respiratory tract infection | |
CN110151851A (en) | Compound and its application based on a kind of Radix Glycyrrhizae medicine pair by honeysuckle | |
CN109350670A (en) | The preparation method of Ynxingchao dropping pills compound | |
KR102358713B1 (en) | Compositions containing Acanthopanax sessiliflorum, Fagopyri Semen and Chaenomelis Fructus extracts for the Improvement of Allergic Rhinitis and Manufacturing Method Thereof | |
CN103432465A (en) | Traditional Chinese medicinal preparation for treating infantile acute suppurative otitis media and preparation method thereof | |
CN114681568A (en) | Cough-relieving and phlegm-reducing composition, substitute tea, candy and preparation method | |
CN114010691B (en) | Qingyu throat-benefiting buccal tablet and preparation method thereof | |
CN104524176A (en) | Traditional Chinese medicine formula for treating swollen sore throat | |
CN106692496B (en) | Compound traditional Chinese medicine buccal tablet and preparation method and application thereof | |
CN114306444A (en) | Traditional Chinese medicine composition for treating respiratory tract infection | |
CN109223956B (en) | Traditional Chinese medicine composition for treating cough and extraction method and application thereof | |
CN115317577B (en) | Traditional Chinese medicine composition for treating children cough | |
CN103948738A (en) | Sore throat relieving anti-inflammatory bird's nest composition and preparation method and application thereof | |
CN109045193A (en) | A kind of sphagitis spray and preparation method thereof | |
CN102247470B (en) | A kind of Chinese medicine composition preventing and treating infant upper respiratory tract infection | |
CN117838812A (en) | Traditional Chinese medicine preparation for treating cough and preparation method thereof | |
CN107913331A (en) | A kind of Chinese and Western medicine compound preparation for treating acute epiglottitis and preparation method | |
CN105395785A (en) | Chinese medicinal formula for treatment of throat inflammation | |
CN106806762A (en) | A kind of Chinese medicine preparation for treating many phlegm bronchiectasis and preparation method thereof | |
CN109420092A (en) | A kind of Chinese medicine composition for treating tonsillitis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |